Lupus & antiphospholipid syndrome
Self-efficacy is associated with a lower probability of damage accrual in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
Authors' conclusion
A better self-efficacy mainly in the managing symptoms and daily activities domains is predictive of a lower risk of damage accrual, even after adjusting for possible confounders.
Study context
- Population
- SLE patients from the Almenara Lupus Cohort
- Participants
- 209 patients563 visits
- Exposure
- Self-efficacy and damage accrual
- Outcome
- Any increase in the SLICC/ACR damage index (SDI) (SLICC/ACR DI)
Methodological detailsgeneralised estimating equations, multivariable models adjusted for possible confounders
- Generalised estimating equations
- Multivariable models adjusted for possible confounders
Main finding
As reported in the abstract
Damage accrual (any SDI increase), multivariable OR per 5 units increase in self-efficacy
Self-efficacy for managing symptoms: OR
0.79 (0.64-0.98) (95% CI)
Self-efficacy for managing daily activities: OR
0.71 (0.54-0.95) (95% CI)
Observational data: associations, not effects.
Further findings
Damage accrual during follow-up
- Accrued damage once
- 41 (19.6%)
- Accrued damage twice
- 2 (1.0%)
Baseline self-efficacy (PROMIS), mean (SD)
- General self-efficacy
- 47.2 (10.4)
- Managing emotions
- 44.6 (8.0)
- Managing symptoms
- 47.7 (8.2)
- Managing daily activities
- 45.5 (7.5)
- Managing social interactions
- 42.9 (7.9)
- Managing medications and treatment
- 43.9 (7.0)
Original publication
Self-efficacy is associated with a lower probability of damage accrual in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort. Clin Exp Rheumatol. Published 24 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →